Eli Lilly & Co (LLY)

On  May 27, Reuters reported that Biohub, a philanthropic venture formed by Meta CEO Mark Zuckerberg and Dr. Priscilla Chan, developed a global model of protein biology to speed up drug discovery.

The anti-obesity drug (AOM) market in the United States is rapidly changing structurally.

The next frontier of human health may not be found in a hospital; it may be unlocked in a laboratory.

Earnings growth has long remained one of the most powerful drivers of shareholder returns in the long term.

In this article, we will look at Jim Cramer’s stock calls on Mad Money, as he highlighted worthy space players and reviewed several of this year’s IPOs.

Strong earnings growth has underscored the need to focus on growth stocks amid an equity market battered by monetary policy uncertainties, surging inflation, and unending geopolitical tensions.

Growth stocks have outperformed value stocks by an average of 7.8% over the past year. Since March, the Morningstar US Growth Index has risen by over 20% compared to a 3.5% gain for value stocks.

On June 11, Emily Roland, the Co-Chief Investment Strategist at Manulife John Hancock Investment Management, joined 'Squawk Box' on CNBC to discuss where investors can find opportunity right now.

In a report dated May 6, 2026, Reuters said that, more than two-thirds through the first-quarter reporting season at that time, S&P 500 companies were on track for their strongest quarterly earnings growth...